Similarly, the NLRP3 inhibitor MCC950 decreased tumour size (average tumour size: 14.77 mm in SGC7901 xenograft mouse models without MCC950 vs. 8.47 mm in those with MCC950) and tumour weight (5.40% in SGC7901 xenograft mouse models without MCC950 vs. 2.82% in those with MCC950) in SGC7901 mouse tumour models (Figure S6D,E). This evidence concerns the gene NLRP3 and neoplasm.